- Home
- BBIO vs PLXS Comparison
BBIO vs PLXS Comparison
Compare BBIO & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- PLXS
- Stock Information
- Founded
- BBIO 2015
- PLXS 1979
- Country
- BBIO United States
- PLXS United States
- Employees
- BBIO N/A
- PLXS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- PLXS Electrical Products
- Sector
- BBIO Health Care
- PLXS Technology
- Exchange
- BBIO Nasdaq
- PLXS Nasdaq
- Market Cap
- BBIO 4.9B
- PLXS 4.5B
- IPO Year
- BBIO 2019
- PLXS 1986
- Fundamental
- Price
- BBIO $23.24
- PLXS $159.63
- Analyst Decision
- BBIO Strong Buy
- PLXS Buy
- Analyst Count
- BBIO 13
- PLXS 5
- Target Price
- BBIO $46.92
- PLXS $133.50
- AVG Volume (30 Days)
- BBIO 1.7M
- PLXS 203.6K
- Earning Date
- BBIO 11-12-2024
- PLXS 10-23-2024
- Dividend Yield
- BBIO N/A
- PLXS N/A
- EPS Growth
- BBIO N/A
- PLXS N/A
- EPS
- BBIO N/A
- PLXS 4.01
- Revenue
- BBIO $217,765,000.00
- PLXS $3,960,827,000.00
- Revenue This Year
- BBIO $3,690.39
- PLXS $8.13
- Revenue Next Year
- BBIO N/A
- PLXS $10.48
- P/E Ratio
- BBIO N/A
- PLXS $39.82
- Revenue Growth
- BBIO 2209.77
- PLXS N/A
- 52 Week Low
- BBIO $21.62
- PLXS $90.18
- 52 Week High
- BBIO $44.32
- PLXS $169.41
- Technical
- Relative Strength Index (RSI)
- BBIO 41.84
- PLXS 62.54
- Support Level
- BBIO $21.72
- PLXS $151.77
- Resistance Level
- BBIO $27.57
- PLXS $158.55
- Average True Range (ATR)
- BBIO 1.42
- PLXS 4.18
- MACD
- BBIO -0.23
- PLXS -0.62
- Stochastic Oscillator
- BBIO 25.98
- PLXS 58.33
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About PLXS Plexus Corp.
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.